Background {#S0001}
==========

Solitary fibrous tumor (SFT) is a benign mesenchymal neoplasm of putative fibroblastic origin. They can occur anywhere in the human body but arise predominantly in the visceral pleura; SFTs in extraserosal sites, especially those involving the central nervous system, are quite infrequent.[@CIT0001]--[@CIT0003] SFTs occurring in the spinal intramedullary locations are extremely rare.[@CIT0004]--[@CIT0008] Although it may be challenging on neuroimages to offer a specific diagnosis of this rare entity, knowledge of this tumor is vital as it has benign features and a possibly better prognosis than some more malignant tumors in this location.[@CIT0004],[@CIT0007] It is crucial to accumulate imaging findings and biological behaviors of spinal intramedullary SFTs given the limited number of reported cases.

Herein, we described a rare spinal intramedullary SFT. On neuroimaging, the tumor appeared as an angiomatous lesion; the preoperative diagnosis is challenging. The clinical manifestations, radiological features, histopathological findings, and follow-up data were presented and discussed.

Case Presentation {#S0002}
=================

History {#S0002-S2001}
-------

A 35-year-old female presented with an 11-month history of progressive numbness in both of her legs. Over the last month, she developed weakness in her left leg and loss of bladder control. Physical examination showed a loss of sensation below the level of crista iliaca and muscle strength of grade 4/5 in the left lower extremity. There was no remarkable finding in her past medical history, and she denied a family history of central nervous system diseases.

Examinations {#S0002-S2002}
------------

The laboratory data were all in the normal range. Magnetic resonance imaging (MRI) showed an intramedullary well-circumscribed 4.3×0.9×1.3 cm mass at the C6-T1 vertebral level and associated spinal cord edema in the rostral region of the lesion. The lesion was isointense on T1-weighted imaging ([Figure 1A](#F0001){ref-type="fig"}) and hyperintense on T2-weighted imaging ([Figure 1B](#F0001){ref-type="fig"}). Homogeneous and bright contrast enhancement was noted after intravenous injection of gadolinium-diethylenetriaminepenta-acetate (Gd-DTPA) ([Figure 1C](#F0001){ref-type="fig"}). A further three-dimensional computed tomographic angiography (CTA) reconstruction was requested, which demonstrated the mass was remarkably enhanced ([Figure 1D](#F0001){ref-type="fig"}), suggesting its rich vascularization; nevertheless, identifying its definite feeding artery is quite challenging.Figure 1(**A**) T1-weighted magnetic resonance imaging showing an isointense mass. (**B**) T2-weighted imaging showing a hyperintense mass with associated spinal cord edema in the rostral region of the lesion. (**C**) Homogeneous enhancement after gadolinium administration. (**D**) Three-dimensional computed tomographic angiography reconstruction showing a high-flow hypervascular lesion.

Operation {#S0002-S2003}
---------

The preoperative suspected diagnosis was spinal hemangioblastoma. The tumor was surgically resected via a posterior midline approach, under neurophysiological monitoring with motor and sensory evoked potentials. Intraoperative findings revealed an intramedullary white-yellowish tumor. There was no cleavage plane between the tumor and the parenchyma of the spinal cord. A gross total resection was achieved.

Pathological Findings {#S0002-S2004}
---------------------

Histological examination revealed uniform spindle cells arranged in interlacing fascicles, with intermingled collagen fiber bundles and a dense reticulin fiber network. The nuclei were oval to elongated without pleomorphism. Mitotic activity and necrosis were absent. There were no psammoma bodies or whorls. Immunohistochemical analysis revealed strong and diffuse immunopositivity with vimentin and CD34, while the tumor was negative for S-100, glial fibrillary acidic protein (GFAP), epithelial membrane antigen (EMA), and CD56. The Ki--67 labeling index was low (\<1%). Based on the immunohistochemical profiles and the histopathological fascicular spindle cell morphology, the lesion was diagnosed as SFT ([Figure 2A](#F0002){ref-type="fig"}).Figure 2(**A**) Haematoxylin and eosin staining (original magnification ×200) showing uniform spindle cells arranged in interlacing fascicles. (**B**) Sagittal, (**C**) coronal, and (**D**) axial contrasted T1-weighted imaging confirming a complete resection of the tumor.

Postoperative Course and Follow Up {#S0002-S2005}
----------------------------------

The postoperative MRI confirmed a complete resection ([Figure 2B](#F0002){ref-type="fig"}--[D](#F0002){ref-type="fig"}), and the postoperative course was uneventful. The paresthesia and weakness in the lower extremities and dysuria were completely relieved seven months postoperatively. The patient was asymptomatic over the subsequent 23-month follow-up. The latest MRI showed no evidence of recurrence.

Discussion {#S0003}
==========

SFTs were initially described in 1931 by Klemperer and Rabin as a mesenchymal tumor arising from the pleura.[@CIT0009] The visceral pleura is the predominant location, while the central nervous system involvement is quite infrequent; SFTs occurring within the spinal cord is extremely rare, with only 18 cases previously reported in the literature.[@CIT0004]--[@CIT0008],[@CIT0010]-[@CIT0021] The relevant literature review was summarized in [Table 1](#T0001){ref-type="table"}. We analyzed the clinical and radiological characteristics of intramedullary SFTs in 18 reported cases together with the current case. The average age at diagnosis was 48.95 ± 17.08 years (range, 17\~83 years). The female-to-male ratio was 1.25:1. The clinical manifestations were nonspecific, including local pain and sensorimotor disturbances. The duration between onset and diagnosis ranged from 1 month to 3 years (mean 15.72 ± 11.35 months). These tumors were predominantly located in the cervical (n=8) and thoracic (n=9) spine, and only one intramedullary SFT in the lumbar spine was reported. Approximately half of these tumors (n=9) were exophytic to the extramedullary compartment. Fifteen patients underwent completely surgical resection, among which tumor recurrent was noted only in one patient during the follow-up; four patients underwent incompletely surgical resection, and one of them experienced tumor recurrence.Table 1Previously Reported Cases of Intramedullary Solitary Fibrous TumorYearAuthorAge (Years) /GenderSymptomsDurationLocationExophytic to Extramedullary CompartmentResectionFollow-UpOutcome1996Carneiro et al[@CIT0010]50/FBilateral lower-extremity pain, numbness and weakness; incontinence3 yearsN.A.YesIncomplete5 yearsRecurrence1997Alston et al[@CIT0011]47/MBrown-Sequard syndrome1 yearT4-5NoComplete2 monthsNo recurrence2000Mordani et al[@CIT0012]33/MFour-extremity paresthesia; bilateral lower-extremity weakness18 monthsC5NoComplete18 monthsNo recurrence2004Kawamura et al[@CIT0013]64/MBrown-Sequard syndrome2 yearsT2-3YesIncomplete6 monthsNo recurrence2004Bohinski et al[@CIT0014]49/FNeck pain and stiffness;\
burning sensation in the left upper extremity1 yearC4YesComplete10 monthsNo recurrence2004Pizzolitto et al[@CIT0015]47/MAnesthesia; four-extremity paresthesia6 monthsC4N.A.Complete12 monthsNo recurrence2005Jallo et al[@CIT0016]41/MAnesthesia; upper-extremity weakness24 monthsC6-7NoComplete3.5 yearsNo recurrence2005Jallo et al[@CIT0016]17/MBack pain; lower-extremity weakness; scoliosis6 monthsT5-6NoComplete1.6 yearsNo recurrence2009Ishii et al[@CIT0005]63/FNeck pain; right upper-extremity numbness, paresthesia, and weakness6 monthsC5NoComplete14 monthsNo recurrenceYearAuthorAge (years)\
/GenderSymptomsDurationLocationExophytic to extramedullary compartmentResectionFollow-upOutcome2010Ciappetta et al[@CIT0006]75/FBilateral lower-extremity weakness and paresthesia1 yearT6-7YesComplete2 yearsNo recurrence2011Fargen et al[@CIT0017]28/FFace, neck and shoulder pain; lower-extremity numbnessN.A.C2-3YesComplete2 yearsNodular enhancement2012Mariniello et al[@CIT0018]75/FBilateral lower-extremity weakness and paresthesia1 yearT6-7N.A.Complete1 yearNo recurrence2014Robert et al[@CIT0019]49/FBilateral lower-extremity numbness and paresthesia1 yearT9-10YesIncomplete6 monthsNo recurrence2014Hwang et al[@CIT0007]48/MRight lower-extremity paresthesia and hyposthesia1 monthC7-T1YesIncomplete6 monthsNo recurrence2015Bruder et al[@CIT0004]83/FLeft lower-extremity weakness and paresthesia; paralysis; incontinence1.5 yearsT8-9YesComplete8 monthsNo recurrence2015Walker et al[@CIT0008]47/FLow-back and right leg pain; right lower-extremity weakness3 yearsL1NoComplete1 yearNo recurrence2016Wang et al[@CIT0020]31/MBilateral lower-extremity weakness and paresthesia3 yearsT1-T5N.A.CompleteN.A.N.A.2019Mansilla et al[@CIT0021]48/N.A.Bilateral lower-extremity paresthesia1 monthT3-T4YesComplete7 monthsNo recurrencePresent caseYang et al35/FLow-extremity numbness and weakness; incontinence11 monthsC6-T1NoComplete23 monthsNo recurrence[^1]

SFTs must be differentiated from hemangioblastoma, hemangiopericytoma, and fibrous meningioma; nevertheless, the preoperative identification is difficult as they can show similar appearance in imaging studies. The confident diagnosis still relies on histopathology. The typical microscopic characteristics of SFTs are fascicular spindle cells, dense collagenous band, and absence of specific structural features such as well-formed lobules, whorls, or psammoma bodies.[@CIT0016] Immunoreactivity of SFTs to CD34 and negative to S-100 and EMA distinguish them from the other spindle cell tumors.[@CIT0007] Additionally, hemangiopericytomas can also be positive for CD34 antigen; nevertheless, these tumors are typically hypercellular with a higher mitotic rate and presence of necrosis; hemangiopericytomas exhibit patchy and focal expression of CD34, whereas SFTs show strong and diffuse reactivity.[@CIT0006]

The natural history and biological behavior of SFTs are as yet unclear, and there appears to be a variation in tumor growth rates and recurrence;[@CIT0001],[@CIT0002],[@CIT0004],[@CIT0006],[@CIT0007],[@CIT0016],[@CIT0022]--[@CIT0024] however, it usually has an indolent course as reflected in the WHO classification of the tumors of the central nervous system. According to the 2007 classification criteria, SFT was classified as an independent benign pathological variation corresponding to grade I.[@CIT0025] However, SFTs show many similarities to more malignant hemangiopericytomas histopathologically; over the past decade, many scholars assume a common spectrum of these tumors, whereas neuropathologists have retained the distinction of these two entities given the historical understanding and distinct clinicopathologic correlations. Hemangiopericytoma is generally considered with high recurrence rates and long-term risk of systemic metastasis.[@CIT0004],[@CIT0026] In the updated WHO classification of CNS tumors (2016 version), these two pathological items were replaced by a new combined term "solitary fibrous tumor/hemangiopericytoma", and a grading system was adopted to identify the low-grade SFT and the higher-grade lesions including hemangiopericytoma and anaplastic hemangiopericytoma.[@CIT0027] Herein, we highlight the importance of making the correct diagnosis in terms of management and prognosis.

SFTs are indolent neoplasms that can be cured by complete surgical resection. As to spinal intramedullary lesions, a surgical strategy including laminotomy and gross total tumorectomy is the optimal option. Surgical resection should be performed carefully under neurophysiological monitoring as these tumors are usually well-circumscribed but can present with a firm spinal cord attachment. Considering the benign nature of SFTs, no adjuvant radiotherapy or chemotherapy is needed in these cases. Recurrence is extremely rare after gross total removal but has been reported after subtotal resection.[@CIT0004] Chemotherapy has been administrated in some recurrent cases, while the therapeutic efficacy remains indefinite.[@CIT0023] SFTs seem to be insensitive to radiotherapy and chemotherapy.[@CIT0023],[@CIT0024],[@CIT0026],[@CIT0028] Though SFTs with malignant transformation has been rarely reported in the literature, expression of Ki-67 can help determine the possibility of malignant transformation; malignant transformation of SFT has only been reported in cases with high expression of Ki-67 (up to 10%).[@CIT0022]

Conclusions {#S0004}
===========

The rarity and the differential diagnosis of this diagnostically challenging tumor should be highlighted. It is crucial for the clinicians to be aware of intraspinal SFT as it can be easily mistaken for more common angiomatous tumors occurring at this site.
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[^1]: **Abbreviation:** N.A., not available.
